Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer

Curitiba 81520060

3 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Chronic Lymphocytic Leukemia, Head and Neck Cancer, Indolent B-Cell Non-Hodgkin Lymphoma, Invasive Fungal Infections, Leukemia, Leukemia, B-cell, Leukemia, Lymphocytic, Nucleophosmin 1-mutated Acute Myeloid Leukemia, Small Lymphocytic Lymphoma

Studies at this site

• A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Recruiting now
• Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer — Recruiting now
• A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL — Recruiting now
• Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML — Running, not enrolling
• Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) — Stopped early
• Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options — Completed
• Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML — Stopped early